consumption of complement did not occur when c4-deficient human serum or normal human sera treated with mg2+- ( ethylene glycol-bis ( beta-aminoethyl ether ) -n , n-tetraacetic acid to specifically impair classical complement pathway activity were used .
C0009498
complement
C0229671
sera